Home › Calculator › NMTRQ Dividend Calculator 2026
NMTRQ Dividend DRIP Calculator 2026
20000000.00% YieldHealthcare9 Meters Biopharma, Inc. · OTC
Price: $0.00 · Annual div: $2.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Calculator settings
Portfolio growth: DRIP vs No DRIP
Annual dividend income growth
💡 What-if scenarios
Click to apply scenario to the calculator
🎯 When NMTRQ pays your bills
Year your monthly dividend income covers each expense (based on current settings)
Share your NMTRQ snowball 📈
$10,000 in NMTRQ → $1.0240512011520145e+51M in 10 years · $85,337,173,410,134,160,000,000,000,000,000,000,000,000,000,000,000,000,000.00/month
About 9 Meters Biopharma, Inc. (NMTRQ) — Dividend Analysis 2026
Operating as a clinical-stage biopharmaceutical firm, 9 Meters Biopharma, Inc. specialized in creating therapies for individuals in North America afflicted by rare digestive illnesses, various gastrointestinal disorders lacking effective treatments, and other debilitating conditions. Its primary therapeutic candidate was Vurolenatide, a long-acting injectable glucagon-like peptide-1, which had advanced to Phase 3 clinical trials for the management of short bowel syndrome. The company's pipeline also included NM-136, a humanized monoclonal antibody aimed at treating obesity and associated conditions; NM-102, a small molecule peptide designed to hinder antigen entry into the systemic circulation; and NM-003, a proprietary long-acting glucagon-like peptide-2 receptor agonist intended to prevent acute graft versus host disease. Furthermore, it partnered on Larazotide, an 8-amino acid peptide undergoing Phase 2 clinical trials for multi-system inflammatory syndrome. Licensing arrangements were established with Amunix, MHS Care Innovation LLC, Alba Therapeutics Corporation, and EBRIS. Headquartered in Raleigh, North Carolina, 9 Meters Biopharma, Inc. initiated a voluntary petition for liquidation under Chapter 7 of the U.S. Bankruptcy Code on July 17, 2023, in the U.S. Bankruptcy Court for the Eastern District of North Carolina.
Compare NMTRQ with similar stocks
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
Get Your Full NMTRQ DRIP Report by Email
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open NMTRQ position with:
🌍 NMTRQ Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold NMTRQ.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 20000000.00% | 19999997.20% | $2,000,000,000 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 17000000.00% | 16999997.20% | $1,700,000,000 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 16000000.00% | 15999997.20% | $1,600,000,000 / yr |
| 🇬🇧 UK ISA | 0% | 20000000.00% | 19999997.20% | $2,000,000,000 / yr |
| 🇬🇧 UK Taxable | 8.75% | 18250000.00% | 18249997.20% | $1,825,000,000 / yr |
| 🇨🇦 TFSA | 0% | 20000000.00% | 19999997.20% | $2,000,000,000 / yr |
| 🇨🇦 CA Taxable | 25% | 15000000.00% | 14999997.20% | $1,500,000,000 / yr |
| 🇦🇺 Super (pension) | 15% | 17000000.00% | 16999997.20% | $1,700,000,000 / yr |
| 🇦🇺 AU Taxable | 30% | 14000000.00% | 13999997.20% | $1,400,000,000 / yr |
| 🇩🇪 DE Taxable | 26.375% | 14725000.00% | 14724997.20% | $1,472,500,000 / yr |
| 🇫🇷 FR Taxable | 30% | 14000000.00% | 13999997.20% | $1,400,000,000 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 NMTRQ Income Goal & Break-Even
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 NMTRQ Dividend Payment Schedule
NMTRQ pays quarterly — 4 times per year. Next ex-div: TBD.
📊 NMTRQ vs Healthcare Benchmarks
How NMTRQ compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for NMTRQ sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ NMTRQ Insider Activity
No recent SEC filings reported in the last 90 days.Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the NMTRQ dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
9 Meters Biopharma, Inc. (NMTRQ) is currently trading at $0.00, 100% below its 52-week high. The current dividend yield is 20000000.00% based on an annual payout of $2.00 per share.
NMTRQ (9 Meters Biopharma, Inc.) — 20000000.00% Dividend Yield Analysis
9 Meters Biopharma, Inc. (NMTRQ) is a healthcare stock currently trading at $0.00 with a dividend yield of 20000000.00%. The company pays an annual dividend of $2.00 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings.
- Above-average yield (20000000.00%) may signal elevated risk — verify sustainability.
Auto-generated from live market data. For educational purposes only — not financial advice.